Effect of Soy in Men With Type 2 Diabetes Mellitus and Subclinical Hypogonadism – A Randomized Controlled Study | Zendy

Thozhukat Sathyapalan | Zendy; Alan S. Rigby | Zendy; Shalender Bhasin | Zendy; Natalie J Thatcher | Zendy; Eric S. Kilpatrick | Zendy; Stephen L. Atkin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Soy in Men With Type 2 Diabetes Mellitus and Subclinical Hypogonadism – A Randomized Controlled Study

Author(s) -

Thozhukat Sathyapalan,

Alan S. Rigby,

Shalender Bhasin,

Natalie J Thatcher,

Eric S. Kilpatrick,

Stephen L. Atkin

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2875

Subject(s) - medicine , endocrinology , soy protein , type 2 diabetes mellitus , isoflavones , glycated hemoglobin , insulin resistance , type 2 diabetes , diabetes mellitus , testosterone (patch) , glucose homeostasis , pathology

Isoflavones found in soy products have a chemical structure similar to estrogen, leading to concerns of an adverse estrogenic effect in men, particularly in those with type 2 diabetes mellitus (T2DM) who have low testosterone levels due to hypogonadism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research